The global diabetes care market is projected to grow at a CAGR of 6.71% between 2025 to 2030. 2024
Rapidly changing lifestyles in many regions across the globe are a major factor driving the growth of this market. An unhealthy lifestyle is increasing the incidence and threat of diabetes among people, thus increasing the demand for diabetes care solutions. The rising disposable income of people is increasing the adoption of these solutions among them. Continuous advancements in technologies, on account of heavy investments being funneled into research and development by major market players, are enhancing the capabilities and reliability of diabetes care solutions, which is further fueling their adoption, thus augmenting the market growth.
Diabetes is a condition that impacts the overall health of humans. It is also known as diabetes mellitus by doctors and is characterized by a symptom in which the blood sugar level of the body becomes very high. Patients with high blood sugar levels develop polyuria, which causes them to frequently urinate or polydipsia and polyphagia which make them excessively hungry and thirsty, respectively.
The body’s ability to produce or use insulin is heavily impacted. Insulin is a hormone present in the body that is released to transport the energy that is produced by processing the food humans eat. Insulin transports the energy produced by the cells and signals the cell to open and receive sugar. If little or no insulin is present in the body, then a significant amount of sugar remains in the blood which can be dangerous.
There are primarily two types of diabetes, type 1 and type 2. Under type 1, the pancreas does not produce insulin, and it usually occurs in humans during childhood or adolescence, though it can occur in adults, the possibility is less. Under type 2 diabetes, the body is not able to produce sufficient insulin or use it properly. It generally occurs after the age of 45. Various factors can contribute to the growth of type 2 diabetes, such as genetic conditions, extra weight, high cholesterol, high blood pressure, and poor communication between cells. Moreover, there is gestational diabetes, which affects women during pregnancy.
Diabetes care devices are manufactured with the aim of helping the patient in the management or monitoring of blood sugar levels due to inadequate insulin production or insulin resistance. Devices such as glucose monitoring devices and insulin delivery devices are instruments used for diabetes care. The diabetes care market is predominantly driven by the rising number of diabetic cases across the globe, improved research and development activities on diabetes, in combination with increasing collaborations and investment by various market players.
Moreover, factors like innovative technologies used for diabetic care devices, improper diet or erratic lifestyle, and increasing need for faster and safer diagnosis and treatment of diabetes drive this market globally. Increased knowledge about this disease and the wide scope of penetration in untapped and emerging markets also contribute to market growth. However, factors like high price charged for diagnosis and treatment of diabetes, low awareness regarding reimbursement issues and patent expiry, and a stringent framework that controls the diabetic procedures act as impediments to the market growth.
North America and Europe are the largest markets for global diabetes care owing to the increasing awareness across their population about diabetes symptoms and the adverse effects of high glucose levels in the blood. Furthermore, strong healthcare infrastructure, better research, and technological advancements, as well as the rising interest of the public in better healthcare facilities, create an opportunity for the diabetes care device market in this region. Government spending on the health sector also provides impetus for the growth of this market in this region.
The market for diabetes care in Europe is witnessing an upward trend on account of the presence of a good chunk of the adult population with diabetes. Hence, the presence of a diabetic population in Europe signifies a market boost for the diabetes care market in the region. Furthermore, technological advancements and healthcare research and development activities also impact market growth significantly. The APAC region also provides tremendous opportunities for its two gigantic countries, India and China are home to many diabetic patients.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients gain a faster and more efficient understanding of the global diabetes care market.
Major industry players profiled as part of the report are Roche Products Limited, Johnson & Johnson Services, Inc., Sanofi-Deutschland GmbH, Novo Nordisk A/S, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Medtronic, Dexcom, Inc., and ARKRAY USA, Inc. among others.
The Global diabetes care market has been analyzed through the following segments:
By Devices
By Drugs
By End-User
By Geography
Updated on : Jan 10, 2025